Last deal

$35M

Amount

Debt Financing

Stage

30.04.2024

Date

3

all rounds

$197.47M

Total amount

date founded

Financing round

General

About Company
SynOx Therapeutics develops treatments for diffuse tenosynovial giant cell tumors.

Industry

Sector :

Subsector :

Also Known As

SynOx

founded date

01.01.2020

Number of employees

Company Type

For Profit

Last funding type

Debt Financing

IPO status

Private

Description

Dublin-based SynOx Therapeutics is a biotech research company founded in 2020 that focuses on developing emactuzumab, a humanized monoclonal antibody that targets and depletes macrophages in tumor tissue, with the aim of treating diffuse tenosynovial giant cell tumors (TGCT) and other indications. The company recently raised €37 million in funding from a syndicate of investors with a strong track record in building successful biopharma companies.
Contacts

Contact Email

Social url

Legal Names

Legal name

SynOx Therapeutics Limited
Similar Companies
1000
Alloplex Biotherapeutics

Alloplex Biotherapeutics

Alloplex Biotherapeutics is a Boston-based company that develops cellular therapeutics to treat cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Boston, MA, USA

total rounds

3

total raised

$21.2M
Prelude Therapeutics

Prelude Therapeutics

Prelude Therapeutics develops novel therapies to target key drivers of cancer cell growth, survival, and resistance.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Therapeutics, Health Care

Location

Wilmington, DE, USA

total rounds

4

total raised

$147M
JW Therapeutics

JW Therapeutics

JW Therapeutics develops and sells cell-based immunotherapies for cancer treatment in China.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Shanghai, China

total rounds

3

total raised

$190M
Y-mAbs Therapeutics

Y-mAbs Therapeutics

YmAbs develops innovative cancer treatments through immunotherapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA

total rounds

4

total raised

$338.8M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$197.47M

Money Raised

Their latest funding was raised on 30.04.2024. Their latest investor Gimv. Their latest round Debt Financing

Date 
Funding Round 
Investors 
Money Raised 
Lead 
19.11.2020
4
$43.91M
Local Amount - EUR 37M
Hercules Capital

Hercules Capital

Hercules Capital, Inc. provides senior secured venture growth loans to high-growth, innovative venture capital-backed companies.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Venture Capital, Finance

Location

Palo Alto, CA, USA

total rounds

2

total raised

$6.5M

count Of Investments

223

count Of Exists

65
HealthCap

HealthCap

HealthCap is a venture capital firm that invests in life sciences globally.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Health Care, Venture Capital

Location

Stockholm, Sweden

count Of Investments

96

count Of Exists

14
Forbion

Forbion

Netherlands-based venture capital firm investing in life sciences and MedTech companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Naarden, Netherlands

count Of Investments

164

count Of Exists

68
Medicxi

Medicxi

Medicxi is a life sciences-focused investment firm with a global presence.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Biotechnology, Venture Capital, Financial Services

Location

London, UK

count Of Investments

44

count Of Exists

3
HealthCap

HealthCap

HealthCap is a venture capital firm that invests in life sciences globally.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Health Care, Venture Capital

Location

Stockholm, Sweden

count Of Investments

96

count Of Exists

14
Co-Investors
Investors
7
3

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
No
Series A
Yes
Series A, Series B
Yes
Debt Financing
Gimv

Gimv

Gimv identifies and supports innovative companies with high-growth potential to become market leaders.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital

Location

Antwerp, Belgium

count Of Investments

154

count Of Exists

49
Forbion

Forbion

Netherlands-based venture capital firm investing in life sciences and MedTech companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Venture Capital, Biotechnology, Financial Services

Location

Naarden, Netherlands

count Of Investments

164

count Of Exists

68
Hercules Capital

Hercules Capital

Hercules Capital, Inc. provides senior secured venture growth loans to high-growth, innovative venture capital-backed companies.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Venture Capital, Finance

Location

Palo Alto, CA, USA

total rounds

2

total raised

$6.5M

count Of Investments

223

count Of Exists

65

People

Employee Profiles
2
Axel Mescheder

Axel Mescheder

Chief Medical Officer

Raymond Barlow

Raymond Barlow

Chief Executive Officer

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range